首页> 美国卫生研究院文献>Molecular Medicine Reports >Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10
【2h】

Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10

机译:使用针对Aldo-酮还原酶家族1成员B10的小干扰RNA抑制肺癌的增殖和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is the leading cause of global cancer-associated mortality. Genomic alterations in lung cancers have not been widely characterized, however, the molecular mechanism of tumor initiation and progression remain unknown, and no molecularly targeted have been specifically developed for its treatment and diagnosis. The present study observed the upregulation of Aldo-keto reductase family 1 member Bio10 (AKR1B10) lung cancer tissues by analyzing two public lung cancer gene expression datasets. Further experiments in silencing AKR1B10 demonstrated that the expression of AKR1B10 was associated with cell proliferation, cell cycle, adhesion and invasion, as well as extracellular-signal-regulated kinase/mitogen activated protein kinase signal pathway. The overexpression of AKR1B10 in lung cancer indicates the important role of AKR1B10 in tumorigenesis. These findings suggest that AKR1B10 could be a potential diagnosis and treatment mark of lung cancer.
机译:肺癌是全球癌症相关死亡率的主要原因。肺癌的基因组改变尚未得到广泛表征,但是,肿瘤发生和发展的分子机制仍然未知,并且尚未针对其治疗和诊断专门开发分子靶向方法。本研究通过分析两个公共肺癌基因表达数据集,观察到Aldo-酮基还原酶家族1成员Bio10(AKR1B10)肺癌组织的上调。进一步沉默AKR1B10的实验表明,AKR1B10的表达与细胞增殖,细胞周期,粘附和侵袭以及细胞外信号调节激酶/促分裂原活化蛋白激酶信号通路相关。 AKR1B10在肺癌中的过度表达表明AKR1B10在肿瘤发生中的重要作用。这些发现表明,AKR1B10可能是肺癌的潜在诊断和治疗标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号